KEY NOTE LECTURE UND PANEL DISCUSSION MIT NATIONALEN UND INTERNATIONALEN STAKEHOLDERN
Samstag, 17. November 13:30–16:15 Uhr
Sigmund Freud University, Raum 1002
1020 Vienna, Freudplatz 1
KEY NOTE LECTURE
HOW TO DEFINE INNOVATION?
How much are we willing or capable to pay for innovation?
Opportunities and Hurdles to access to innovation – a global perspective
Suerie Moon, MPA, PhD, Director of Research and Co-Chair, Forum on Global Governance for Health at Harvard University, Boston, MA, USA, Research Director Graduate Institute of International and Development Studies, Geneva, Switzerland
RESPONSE FROM INDUSTRY AND LESSONS LEARNED
Jürgen Raths, MD, Executive Consultant, Managing Director Cordée Consulting, Geneva
PANEL DISCUSSION
VALUE AND PRICE OF INNOVATION IN PHARMACEUTICALS AND DEVICES
Opportunities and Hurdles for access to innovation
Moderation: Univ.-Prof. Dr. Heinrich Klech, CEO VSCR
Teilnehmer:
Univ.-Prof. Dr. Ernst Agneter, MBA, Executive Board of Association of the Austrian Pharmaceutical Industry, Chairman of the Pharmig working group Health Economics & Reimbursement
Dr. Anna Bucsics, Former Department Head, Department of Pharmaceutical Affairs, Federation of Austrian Social Insurance Institutions
Dr. Martin Gleitsmann, Head of Department of Social Policy and Health, Austrian Federal Economic Chamber
Dr. Vladimir Kopernicky, Vice President, International Medical Affairs, Eli Lilly
Dr. Sylvia Nanz, Medical Director Pfizer Austria
Mag. Ingo Raimon, President of forum of the research based pharmaceutical industry Austria, FOPI
Dr. Wolfgang Wein, General Manager Merck Austria
Priv.-Doz. Dr. phil. Claudia Wild, Director of Ludwig Boltzmann Institut, HTA
Wir ersuchen bis zum 12.11.2018 um Ihre Anmeldung unter office@vscr.at